Avalo Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
AVTX
CUSIP
05338F306
Type
Equity
Class
COM NEW
Num filers
101
Total reported value, excl. options
$464M
Manager Report Date Value ($000) Shares